Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2025-12-24 @ 3:06 PM
NCT ID:
NCT06621459
Eligibility Criteria:
Inclusion Criteria:
* Adult patient
* Patient who has received adjuvant ABEMACICLIB in combination with hormone therapy
* Patient with localized RH+ HER2 non-amplified breast cancer and eligible for treatment with ABEMACICLIB according to the recommendations of the MA (Marketing Authorization) as defined below:
* 4 ipsilateral positive axillary lymph nodes OR
1. to 3 ipsilateral positive axillary lymph node(s) with at least one of the following two criteria: histological grade 3 or primary tumor size ≥5 cm
Exclusion Criteria:
* Patients under legal protection (guardianship, trusteeship, etc.)
* Refusal to participate
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06621459
Study Brief:
Protocol Section:
NCT06621459